Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
BMJ Case Reports
|
September 11, 2012
Clostridium septicum sepsis and its implications
Muhammad Khalid, Rajeka Lazarus, Ian C J W Bowler, et al.
American Journal of Clinical Pathology
|
February 18, 2005
The risk of metachronous neoplasia in patients with serrated adenoma
Rajeka Lazarus, Oili E Junttila, Tuomo J Karttunen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 21, 2012
Pneumococcal polysaccharide vaccine efficacy and routine use of conjugate vaccines in infants: there is no need for a vaccine program in older adults at present
Johannes Trück, Rajeka Lazarus, Ingileif Jonsdottir, et al.
Age and Ageing
|
July 24, 2004
Lesson of the week: perils of pessaries
Luke D Wheeler, Rajeka Lazarus, Jared Torkington, et al.
Journal of Clinical Microbiology
|
May 20, 2011
Acute necrotizing sinusitis caused by Staphylococcus lugdunensis
Philippa C Matthews, Rajeka Lazarus, Andrew Protheroe, et al.
The Journal of Infectious Diseases
|
December 5, 2013
The effect of chronic cytomegalovirus infection on pneumococcal vaccine responses
Daniel O'Connor, Johannes Trück, Rajeka Lazarus, et al.
Immunobiology
|
June 19, 2012
The zwitterionic type I Streptococcus pneumoniae polysaccharide does not induce memory B cell formation in humans
Johannes Trück, Rajeka Lazarus, Elizabeth A Clutterbuck, et al.
Vaccine
|
September 24, 2024
Comparison of assays used to detect antibody response in COVID-19 vaccine trials: Results from of a UK multi-Centre randomised controlled trial to determine the immunogenicity responses of COVID-19 vaccines administered concomitantly with seasonal influenza vaccines (ComFluCOV)
Rajeka Lazarus, Rosie Harris, Russell Thirard, et al.
Trials
|
January 23, 2024
Working under short timescales to deliver a national trial: a case study of the ComFluCOV trial from a statistician's perspective
Rosie Harris, Russell Thirard, Sarah Baos, et al.
The Lancet. Infectious Diseases
|
September 8, 2022
Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE): interim analysis of a randomised, controlled, phase 3, immunobridging trial
Rajeka Lazarus, Benedicte Querton, Irena Corbic Ramljak, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
BMJ Case Reports
|
September 11, 2012
Clostridium septicum sepsis and its implications
Muhammad Khalid, Rajeka Lazarus, Ian C J W Bowler, et al.
American Journal of Clinical Pathology
|
February 18, 2005
The risk of metachronous neoplasia in patients with serrated adenoma
Rajeka Lazarus, Oili E Junttila, Tuomo J Karttunen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 21, 2012
Pneumococcal polysaccharide vaccine efficacy and routine use of conjugate vaccines in infants: there is no need for a vaccine program in older adults at present
Johannes Trück, Rajeka Lazarus, Ingileif Jonsdottir, et al.
Age and Ageing
|
July 24, 2004
Lesson of the week: perils of pessaries
Luke D Wheeler, Rajeka Lazarus, Jared Torkington, et al.
Journal of Clinical Microbiology
|
May 20, 2011
Acute necrotizing sinusitis caused by Staphylococcus lugdunensis
Philippa C Matthews, Rajeka Lazarus, Andrew Protheroe, et al.
The Journal of Infectious Diseases
|
December 5, 2013
The effect of chronic cytomegalovirus infection on pneumococcal vaccine responses
Daniel O'Connor, Johannes Trück, Rajeka Lazarus, et al.
Immunobiology
|
June 19, 2012
The zwitterionic type I Streptococcus pneumoniae polysaccharide does not induce memory B cell formation in humans
Johannes Trück, Rajeka Lazarus, Elizabeth A Clutterbuck, et al.
Vaccine
|
September 24, 2024
Comparison of assays used to detect antibody response in COVID-19 vaccine trials: Results from of a UK multi-Centre randomised controlled trial to determine the immunogenicity responses of COVID-19 vaccines administered concomitantly with seasonal influenza vaccines (ComFluCOV)
Rajeka Lazarus, Rosie Harris, Russell Thirard, et al.
Trials
|
January 23, 2024
Working under short timescales to deliver a national trial: a case study of the ComFluCOV trial from a statistician's perspective
Rosie Harris, Russell Thirard, Sarah Baos, et al.
The Lancet. Infectious Diseases
|
September 8, 2022
Immunogenicity and safety of an inactivated whole-virus COVID-19 vaccine (VLA2001) compared with the adenoviral vector vaccine ChAdOx1-S in adults in the UK (COV-COMPARE): interim analysis of a randomised, controlled, phase 3, immunobridging trial
Rajeka Lazarus, Benedicte Querton, Irena Corbic Ramljak, et al.
Page
of 5